Carotid plaque instability and ischemic symptoms are linked to immaturity of microvessels within plaques  by Dunmore, Benjamin J. et al.
BASIC RESEARCH STUDIES
Carotid plaque instability and ischemic symptoms
are linked to immaturity of microvessels within
plaques
Benjamin J. Dunmore, PhD,a Mark J. McCarthy, PhD, FRCS,b A. Ross Naylor MD, FRCS,b
and Nicholas PJ Brindle, PhD,b Cambridge and Leicester, United Kingdom
Background: Instability and rupture of carotid atherosclerotic plaques leads to thromboemboli and ischemic symptoms.
Angiogenesis occurs within atherosclerotic plaques, and plaque vulnerability and symptomatic carotid disease have been
associated with increased numbers of microvessels. In addition to microvessel number, it is possible that the phenotypes
of intraplaque vessels could influence plaque stability. To test this, the morphology andmaturity of vessels within plaques
from symptomatic and asymptomatic patients was determined.
Methods: Carotid plaques were collected after endarterectomy from a cohort of 13 asymptomatic patients and 30
symptomatic patients. Plaques were sectioned and immunostained for the presence of endothelial cells, vascular smooth
muscle cells, macrophages, and vascular endothelial growth factor. Sections were assessed for microvessel morphology,
maturity as judged by smooth muscle cell cover, and the presence of vascular endothelial growth factor and macrophages.
Results: Two types of vascular structure were observed within plaques, microvessels and dilated, highly irregular
multilobular vessels. These irregular dysmorphic vessels were found almost exclusively in plaques from symptomatic
patients. The dysmorphic vessels lacked smooth muscle cells and were highly immature. Plaques also contained vascular
endothelial growth factor, and this was observed adjacent to the dysmorphic vessels. This growth factor was found
colocalized with macrophages.
Conclusions: Symptomatic carotid plaques contain abnormal, immature microvessels similar to those found in tumors and
healing wounds. Such vessels could contribute to plaque instability by acting as sites of vascular leakage by inflammatory
cell recruitment. The immature vessels within plaques may be therapeutic targets for promoting plaque stabilization.
(J Vasc Surg 2007;45:155-9.)
Clinical Relevance:This report shows for the first time, to our knowledge, that patients with symptomatic carotid disease,
but not asymptomatic patients, have carotid plaques that contain highly immature dysmorphic microvessels. Such
microvessels occur in tumors and wound healing. They are recognized as unstable and as sites of vascular leakage and
inflammation. These vessels are likely to contribute to the plaque instability associated with symptoms and may be
therapeutic targets for promoting plaque stabilization.Most strokes associated with carotid artery disease ap-
pear to occur because of thromboembolic events.1 These
thromboemboli arise from atherosclerotic plaques, and the
frequency of embolization is increased in patients with
recent symptoms, including transient ischemic events.2,3
Indeed, ischemic symptoms are strong predictors of stroke
in patients with internal carotid artery stenosis.4 Impor-
tantly, formation of thromboemboli are related not to
From the Department of Obstetrics and Gynaecology, University of Cam-
bridge,a and Department of Cardiovascular Sciences, University of Leic-
esterb.
This work was supported by a grant from the Stroke Association.
Competition of interest: none.
Reprint requests: Mark J McCarthy, PhD, FRCS, Vascular Surgery Group,
Department of Cardiovascular Sciences, University of Leicester, RKCSB, PO
Box 65, Leicester LE2 7LX, United Kingdom (e-mail: lmcc30@aol.com).
0741-5214/$32.00
Copyright © 2007 by The Society for Vascular Surgery.
doi:10.1016/j.jvs.2006.08.072plaque size but plaque instability, with increased emboliza-
tion occurring at ulcerated plaques and thrombosis associ-
ated with plaque rupture.2,5 Thinning of the fibrous cap of
the plaque, foam cell, macrophage and leukocyte infiltra-
tion, and increased inflammation are all more common in
symptomatic plaques and are characteristic of plaque vul-
nerability.5-7
Angiogenesis has been noted in atherosclerotic plaques
of coronary vessels, where it has been linked with plaque
growth, rupture, thrombosis, and intraplaque hemorrhag-
ing.8-10 The stage in plaque development at which neovas-
cularization occurs has not been precisely defined. Neoves-
sels have been observed in early fatty streaks and appear to
become more prominent and numerous as the lesion ad-
vances.11
The importance of neovessel formation for growth of
atherosclerotic plaques has been revealed in studies with
the Apo E transgenic mouse model, where inhibition of
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lesion growth.12 Neovascularization has also been noted in
carotid atherosclerosis, and symptomatic carotid disease is
associated with elevated intraplaque neovasculariza-
tion.11,13,14 These finding suggest angiogenesis within the
carotid plaque could contribute to its vulnerability. In
addition to the number of intraplaque vessels, it is also
possible that the phenotypes of the neovessels will be
important in determining plaque stability. Thus, immature
intraplaque vessels could act as sites of inflammatory cell
infiltration, leakage, and intraplaque hemorrhaging owing
to the activated phenotype and poor integrity of such
vessels.15,16
In the present study, we examined the maturity of
neovessels within carotid plaques that were removed from
patients who had undergone carotid endarterectomy for
both symptomatic and asymptomatic carotid disease. We
also sought to determine whether any relationship existed
between intraplaque vessel maturity and symptomatology.
MATERIALS AND METHODS
Patients. This research was approved by the local Eth-
ics Committee. Carotid plaques were collected after endar-
terectomy from a consecutive cohort of 43 patients. Preop-
eratively, patients had a 70% internal carotid artery
stenosis determined by color-coded duplex ultrasonogra-
phy scanning.17 Thirteen patients were asymptomatic, and
30 were symptomatic: 5 had amaurosis fugax, 20 had
transient ischemic attacks lasting 24 hours within the
previous 6 months, and 5 had a cerebrovascular accident
with recovery before surgery. The degree of stenosis be-
tween symptomatic and asymptomatic patients, 80% vs
82%, was not significantly different by Mann-Whitney U
test. No difference was noted between symptomatic and
asymptomatic groups with regard to risk factors. Median
age was 73 years (range, 60 to 82 years) for symptomatic
patients and 70 years (range, 57 to 78 years) for asymptom-
atic. No significant difference was found with respect to sex
between the two groups.
Immunocytochemical staining. Antibodies were
from DakoCytomation (Glostrup, Denmark) unless other-
wise stated. Carotid endarterectomy samples were removed
whole, with minimum trauma to plaques, and placed im-
mediately in 4% formalin. Plaques were decalcified, dehy-
drated, embedded, and 4-m sections were cut. Sections
were probed with antibodies recognizing endothelial cells
(anti-CD34; Novacastra, Newcastle, UK), smooth muscle
cell (SMC) actin, macrophages (anti-CD68), and panvas-
cular endothelial growth factor (VEGF) (Santa Cruz Bio-
technology, Santa Cruz, Calif). Bound antibody was de-
tected with the Duet/ABC system (DakoCytomation).
For each plaque, at least three sections were viewed by
two independent observers blinded to the patient’s symp-
toms. No significant difference was found for interobserver
variation (  0.8). In every section, all vessels were exam-
ined and categorized as class I or class II, as indicated in
Results. The percentage of plaques containing each class of
vessel was recorded. Within each section, all microvessels ineach class were scored for extent of SMC coverage as
substantial (75% to 100% coverage of vessel perimeter),3;
moderate (50% to 75%), 2; low (25% to 50%), 1; and
undetectable, 0. The mean score for each vessel class was
recorded.
Statistical analysis. Nonparametric continuous vari-
ables were compared by using the Mann-Whitney U test.
Categoric data were analyzed with the Fisher exact test.
Statistical significance was taken as P  .05.
RESULTS
Symptomatic lesions contain aberrant immature
microvessels. It has been previously reported that symp-
tomatic carotid plaques contain increased numbers of mi-
crovessels compared with asymptomatic lesions.11,13,14 In
the present study, we examined the nature of the microves-
sels within these plaques. Microvessels were visualized
within plaques by immunostaining, and Fig 1 shows repre-
Fig 1. Morphology of neovessels within carotid atherosclerotic
plaques. A, Representative section of plaque from symptomatic
patient illustrates neovessel morphologies designated classes I and II.
B, Percentage of plaques positive for each class of neovessel for
plaques from asymptomatic (white bars) and symptomatic (black
bars) patients. **Significant difference between asymptomatic and
symptomatic group (P  .02).sentative images of intraplaque vessels. Two distinct types
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microvessels and dilated, highly irregular multilobular ves-
sels (Fig 1). For the purposes of this study, we designated
microvessels as class I, and the highly irregular vessels, as
class II. The criteria for identifying the irregular vessels was
their multilobular morphology, although the class II vessels
were larger than class I vessels, with a median cross-section
area of 0.125 mm2 for class II and 0.0025 mm2 for class I.
The occurrence of the vessel types was assessed in symp-
tomatic and asymptomatic plaques (Fig 1, B). A significant
association was found between symptomatology and the
presence of the irregular vessels within plaques (Fig 1, B).
The irregular enlarged vessels found in symptomatic
lesions are reminiscent of the neovessels observed in a
number of pathologic situations, including growth of some
tumors and wound healing.18,19 Such neovessels are often
referred to as immature because they have not acquired the
coating of smooth muscle cells associated with mature
vessels.16 It was of interest therefore to assess the matura-
tion state of intraplaque vessels by immunostaining for the
presence of smoothmuscle cells. As shown in representative
images in Fig 2, class I microvessels possessed a tight coat of
smooth muscle cells. The class II irregular vessels appeared
to be deficient in smooth muscle cells, however, with areas
entirely lacking in SMA staining, and where smooth muscle
cells were detected, they were poorly organized (Fig 2, A).
The intensity of smooth muscle cell coverage was assessed
in both symptomatic and asymptomatic plaques (Fig 2, B).
Almost no smooth muscle cells were associated with the
irregular vessels that were present only in symptomatic
plaques.
Immature microvessels are associated with local
VEGF andmacrophage accumulation. A key function of
perivascular cells is to support the underlying endothelium
by providing survival signals.20,21 In the absence of perivas-
cular support, cells microvessels undergo regression unless
maintained by growth factors within the microenviron-
ment. We therefore examined plaques for the presence of
VEGF. VEGF was observed within plaques and, interest-
ingly, could be seen localized both adjacent to vessels and at
distant sites (Fig 3, A) . VEGF immunoreactivity was ob-
served adjacent to class I and class II vessels, although class II
vessels h a d more intense staining than class I (Fig 3, B).
Potential sources of angiogenic growth factors include
inflammatory cells; thus, so sections were stained for the
presence of macrophages. Macrophage infiltration was ev-
ident adjacent to vessels (Fig 3). Furthermore, these areas
of macrophage accumulation correlated with areas of
VEGF expression, suggesting the macrophages as a possi-
ble source of this growth factor within the plaques. There
was slightly more staining for macrophages adjacent to the
irregular vessels compared with class I vessels, although this
did not reach statistical significance (Fig 3, C).
DISCUSSION
Here we provide the first evidence, to our knowledge,
for dysmorphic, highly dilated, immature microvessels
within carotid plaques and their association with symptom-atology. Because symptomatology likely reflects thrombo-
embolic activity,2,3 it suggests that the aberrant intraplaque
vessels are linked to events at the plaque leading to neuro-
logic events. It should be noted, however, that these data
are correlative, and further work will be required to estab-
lish whether a causal link exists between the presence of
these intraplaque vessels and neurologic events.
An important observation of the study was that the
aberrant intraplaque vessels were largely devoid of a smooth
muscle cell covering. Lack of mural cell coating is typically
taken as an indication that vessels have not matured into
fully functional patent vessels, and they are usually referred
to as “immature” for this reason.16 The timescale over
Fig 2. Dysmorphic vessels within symptomatic plaques have poor
smooth muscle cell (SMC) coverage. A, Representative photomi-
crographs illustrate paucity of SMC on class II vessels. Areas of
negative SMC staining (arrowheads) and disorganized SMC (double
arrowheads) on class II vessels (arrows) are illustrated. Panels a and c
are stained for endothelial cells; b and d are stained for SMC actin.
(immunostain, magnification  100) B, SMC coverage of in-
traplaque vessels. Values are mean and SEM. *P  .05 vs class I
vessels.which such vessels appear in plaques has yet to be deter-
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immature vessels could form late in plaque evolution in
response to an increasingly proangiogenic microenviron-
ment within the plaque. In this respect, the similarly abnor-
mal vessels seen in some tumors are thought to arise, at least
in part, due to the angiogenic milieu within the tumor.16
Interaction of smooth muscle cells with microvessels is
important for suppressing leakage and promoting stability
and quiescence of the vessels.16,22 The absence of perivas-
cular support in the aberrant plaque vessels suggests they
may be sites where vascular leakage of blood into the plaque
could occur. This could contribute to plaque friability by
allowing intraplaque accumulation of red blood cells,
which can act to expand the necrotic core of the plaque.23
Furthermore, platelets and red blood cells leaked within the
plaque can enhance macrophage activation and foam cell
formation after their phagocytosis.24,25 It should also be
noted that immature microvessels with a proangiogenic
phenotype are likely to provide entry points for intraplaque
infiltration with lymphocytes and macrophages.23 In-
traplaque macrophages and lymphocytes are rich sources of
growth and inflammatory factors as well as matrix metallo-
proteases, which have been implicated in promoting plaque
instability.5,7 It is possible, therefore, that these immature
intraplaque vessels contribute to symptomatology by pro-
Fig 3. Vascular endothelial growth factor (VEGF) expre
plaques. A, Representative photomicrographs illustrate V
II vessels (arrows, and colocalization of VEGF (arrowhea
staining, (b) immunolocalization of macrophages and (c)
 100) B, VEGF immunostaining adjacent to vessels a
immunostaining adjacent to vessels as mean and SEM.moting plaque instability. In future studies, it will be ofconsiderable interest to determine the inflammatory activa-
tion state of the intraplaque vessel types and the relation-
ship of this to plaque stability.
The origin of the aberrant intraplaque vessels is not
clear. One possibility is that localized elevations in concen-
trations of angiogenic growth factors within the plaque
may result in remodelling of nearby vessels. Such remodel-
ling could involve expansion of microvessels without, or
preceding, a concomitant increase in smooth muscle cover.
Indeed, highly enlarged irregular vessels, such as those seen
in the symptomatic plaques, are often observed in condi-
tions of elevated VEGF.26-28 A potential source of the
angiogenic factors could be infiltrating inflammatory cells.
The remodelled vessels, if immature, could act as sites of
further recruitment of inflammatory cells. This could lead
to additional increases in VEGF concentration and further
vessel remodelling and result in the highly dilated irregular
vessels observed. The localization of macrophages and
VEGF expression seen adjacent to these vessels in the
current study may therefore have resulted from the pheno-
type of the immature vessels and contribute to their main-
tenance and even expansion.
Although further work is required, the findings of the
present study may have clinical relevance. Thus, the char-
acteristics of the irregular intraplaque vessels may allow
associated with neovessels within carotid atherosclerotic
expression within symptomatic plaques containing class
d macrophages (double arrowheads). Panel a endothelial
unolocalization of VEGF. (immunostain, magnification




s methem to be detected and distinguished from other in-
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ogies, such as magnetic resonance or contrast ultrasound
imaging.29,30 Such information may be valuable for detec-
tion of vulnerable plaques. Furthermore, if the appearance
of irregular vessels is found to contribute to plaque insta-
bility, these vessels could be attractive therapeutic targets.
For example, it may be possible to suppress transition to
symptomatic plaques, or even stabilize already symptomatic
plaques, by inhibiting formation or inducing regression of
these intraplaque vessels. In this context, it would be inter-
esting to test the effects of current antiangiogenic com-
pounds on growth and regression of the class II vessels.
CONCLUSION
This study has shown that symptomatic atherosclerotic
plaques are associated with the presence of abnormal in-
traplaque vessels. These vessels are immature and have
adjacent macrophage infiltration and elevated VEGF. Such
vessels could contribute to plaque friability by acting as sites
of vascular leakage and inflammatory cell recruitment
within the plaque.
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